Financial Year 2024: Weleda Achieves Record Turnover and Significantly Improves Profitability
Turnover increased by 8.3% to EUR 456.2 million.
Operating profit (EBIT excluding special effects) more than doubled from EUR 13.4 million to EUR 28.3 million.
Both business units – Natural Cosmetics and Pharmaceuticals – delivered strong growth worldwide.
Strategic growth drivers: internationalisation, digitalisation, innovation, and premiumisation.
CEO Tina Müller: '2024 was a year of renewal for Weleda – and a very strong year for us economically. Our strategy of growth with responsibility is working.'
CEO Tina Müller: 'We have once again started the new financial year with strong momentum. We will continue our sustainable growth path with many innovations.'
Weleda AG, the global market leader in certified natural cosmetics and anthroposophic medicines, can look back on a very successful 2024 financial year. Turnover rose by 8.3% to EUR 456.2 million (previous year: EUR 421.2 million) – the highest in the company's history. At the same time, Weleda significantly improved profitability, more than doubling its operating profit (EBIT excluding special effects) to EUR 28.3 million (previous year: EUR 13.4 million).
Both business units and all regions worldwide contributed to dynamic growth. In Natural Cosmetics, sales rose by 8.2% to EUR 367.9 million (previous year: EUR 340.1 million), while the Pharmaceuticals unit increased sales by 8.7% to EUR 88.3 million (previous year: EUR 81.2 million). '2024 was a year of renewal for Weleda – and a very strong year for us economically. Our positive performance shows that our strategy of growth with responsibility is working,' says Tina Müller, CEO of Weleda AG. 'We have taken the right steps to further strengthen our competitiveness and resilience. Our focus on the four strategic growth driversof innovation, premiumisation, digitalisation, and internationalisation is proving effective.'
International expansion – core D-A-CH region shows strong recovery
In 2024, Weleda continued to expand its international business, achieving double-digit sales growth in major markets such as Asia and the USA, as well as in Eastern Europe, Southern Europe, and the Benelux countries. The company also returned to a clear growth trajectory in its core D-A-CH region after several challenging years. In Germany – the company's largest single market – sales rose by 6.2%. In Switzerland, turnover increased by 7.4%. This positive development in the D-A-CH region was supported by the successful launch of new webshops in both countries in spring 2024.
Weleda demonstrated strong innovative capacity in 2024. New products such as the rejuvenating Blue Gentian & Edelweiss facial care and the extended Rosemary hair care line were key growth drivers in the cosmetics segment. In the pharmaceuticals segment, the strategic focus on core product categories – eye health, stress & sleep, and digestion – had a positive impact on performance. Eye preparations in particular contributed to growth, with a 32% increase in sales.
Reduced complexity – increased efficiency
At the beginning of 2024, Weleda implemented a new organisational structure, introducing dedicated business units for Natural Cosmetics and Pharmaceuticals and giving them greater entrepreneurial responsibility. Strong central functions were also created, and expertise consolidated across the company. 'The new organisational structure has made us faster, more efficient, and more effective, which benefits our customers worldwide,' says Tina Müller.
Sustainability by conviction
Amid ongoing transformation, Weleda remains true to its core values. Sustainability continues to underpin its business model. The company actively supports biodiversity, healthy soils, and the circular economy. In 2024, Weleda sharpened its sustainability strategy and set ambitious new targets. The company aims to achieve net zero for Scope 1 and 2 emissions by 2040, and to reduce Scope 3 emissions by 80% by that time.
Stable growth through innovation
The future of Weleda will be shaped more than ever by innovation. The recently introduced multi-generation skincare line minLen is the first in a new series of product ranges in Natural Cosmetics launching in 2025. With this line, as well as the new Weleda Cell Longevity facial care, the company is moving further into the premium segment and expanding its distribution channels. Both product lines will be available in perfumeries.
Weleda is also strengthening its innovative capabilities in Pharmaceuticals. Under the name Futurum, an interdisciplinary team has been formed to further develop anthroposophic medicines, strengthen their scientific basis through research, and introduce new application formats to benefit patients.
A modernised brand for long-term success
The strategic evolution of Weleda is also reflected in its modernised brand image, designed to appeal to younger target groups. The company has refreshed its visual identity, including the logo, to make it more contemporary and premium. The logo is now accompanied by a word mark that highlights the company's values and origins: 'Natural Science' or 'Swiss Natural Science'. Weleda products remain certified natural, while the company continues to draw on its own research and development to optimise the power of medicinal plants for maximum effectiveness and vitality-enhancing benefits. The new brand identity will be rolled out across markets throughout 2025.
'We have set the course for long-term success in every respect. We have again started the new financial year with strong momentum and will continue on our growth path with many innovations,' says Tina Müller.
About Weleda
Weleda AG is a Swiss public limited company headquartered in Arlesheim, near Basel. Active in over 50 countries, Weleda employs around 2,200people worldwide. It is the world's leading manufacturer of certified natural cosmetics and anthroposophic medicines. Weleda cultivates six of its own biodynamic gardens and is especially committed to promoting biodiversity and maintaining healthy soils. Weleda is a certified B Corp.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 hours ago
- Yahoo
Novaturas Group Reports Audited Results for 2024
The tour operator Novaturas Group reported audited revenues of EUR 201 million for 2024, having served 239 thsnd. travelers across the Baltic States. Compared to 2023, this represents a 3.6% decline in revenue and an 8% decrease in traveler numbers (down from 259 thsnd. in 2023). Despite a profitable final quarter, the company ended the year with a net loss. '2024 was a volatile year. The first half was particularly challenging, as we operated in an oversupplied market, which was reflected in our January–June results, with EBITDA standing at a negative EUR 1.6 million. However, decisive actions such as optimizing our travel program, swiftly responding to demand changes, and focusing on customer experience helped reverse the trend. In the fourth quarter, we returned to profitability with an adjusted EBITDA of EUR 2.3 million. While this wasn't enough to offset the year's total loss, it confirms we're on the right track in the long-term perspective,' said Kristijonas Kaikaris, CEO of Novaturas Group. Operational results surpassed forecasts Mid-2024, following a loss-making first half, Novaturas forecasted a full-year EBITDA (earnings before interest, taxes, depreciation, and amortization) of EUR -4.1 million and a net loss of EUR 5.1 million. However, a stronger than expected autumn and winter season led to significantly better unaudited results: EBITDA of EUR -863 thsnd. and a net loss of EUR 2.5 million. Audited results revealed even more positive numbers: the adjusted annual EBITDA came in at -EUR 449 thsnd., and the operating net loss (excluding a further-mentioned one-off goodwill impairment) was EUR 1.9 million. The final audited net loss, however, reached EUR 7.6 million due to a one-off, non-cash EUR 5.7 million goodwill impairment (identified through a goodwill impairment test), primarily reflecting a more conservative outlook for the Estonian market. The test for goodwill impairment is a standard accounting procedure regularly performed to ensure a true and fair view of the company's financial reporting. The impairment of goodwill does not affect the Group's cash flows or its ability to generate value, and merely reflects a reduction in the book value of equity. Audit disclaimer removed Novaturas also announced that its 2024 audit report no longer includes the previous disclaimer related to the balance of settlements with international suppliers. This means that the company has resolved these discrepancies, reconciled and accounted for outstanding amounts with suppliers, and provided accurate reports that reflect its financial position. It is clarified that the audit reports for the year 2024 and 2023 for Novaturas were conducted by the same audit firm – UAB Ernst & Young Baltic. Strategic investor partnership begins In early 2025, Novaturas entered a new phase – 4 shareholders have signed an agreement to sell shares to a strategic investor, Turkish tourism businessman and investor Neset Kockar, who owns businesses in international aviation, real estate, tourism and other industries. At the end of April this year, the company completed the first stage of the transaction, under which Mr. Kockar acquired a 23.2% stake in Novaturas from three individual shareholders. The second and final stage of the planned transaction, after which Mr. Kockar would hold 33.19% of Novaturas shares, is expected to be completed in the autumn. According to K. Kaikaris, attracting a strategic investor with international tourism business holdings opens up new opportunities for synergy and growth for Novaturas. Mr. Kockar provided the company with a short-term loan of EUR 1 million, which was later extended and increased to EUR 2 million. Novaturas' near-term plans include a review of the company's strategy, the development of collaboration opportunities with the new shareholder's businesses in travel destinations popular among Baltic travellers, and the launch of new, more attractive offerings for travellers from Lithuania, Latvia, and Estonia, including a wider hotel selection and other services. Additionally, Novaturas has started testing a hybrid travel packaging solution that will allow clients to access a significantly wider range of hotel options and more diverse pricing. Once the testing phase – currently being conducted internally on selected routes – is completed, the company plans to roll out this solution to travel agencies, enabling them to conveniently and quickly create more tailored travel packages with Novaturas for their clients. Travel trends, destinations, and operational efficiency In 2024, the company successfully leveraged its broadest portfolio of destinations and increased traveller numbers to routes that ensured higher operational efficiency. By closely monitoring customer preferences, the company adjusted volumes throughout the year to better meet the needs of its travellers. Among the fastest-growing destinations last year were trips to Spain – the number of travellers to Malaga, Barcelona, and Mallorca increased by 149% compared to 2023. The company also successfully increased long-haul travel sales by 8%. The number of travellers to Vietnam grew by 367%, to Phuket in Thailand by 23%, and to Zanzibar in Tanzania by 21%. In the group travel segment, sports and activity-based trips gained popularity, with Turkey, Greece (Heraklion), Montenegro, Egypt, Cyprus, and Portugal (Faro) being the most favoured destinations. For ski holidays, Italy (Bergamo) was the top choice. Last year, Novaturas together with partners organised a record-breaking workation travel – flying 2,500 employees of Tesonet Accelerator companies to Turkey. This trip required a total of 12 planes and 48 buses. In the fourth quarter of last year (compared to the same period in 2023), Novaturas successfully reduced the share of last-minute bookings in total sales – a segment that typically impacts overall financial performance negatively. Moreover, the company's aircraft load factor increased to 98.9% in the fourth quarter, compared to 96.7% during the same period in 2023. Audited results of Novaturas Group for the year 2024 (EUR 000's): Financial indicators 2024 2023 2022 Revenue 200,878 208,331 196,676 Gross profit 20,742 26,227 18,127 EBITDA (6,132) 5,241 415 Adjusted EBITDA (449) 5,241 415 Net profit (loss) (7,604) 3,372 (1,683)The Novaturas Group is a tour operator offering the widest range of travel destinations from the Baltic States. It has been operating in the region for more than 25 years. The company offers summer and winter recreational, sightseeing, exotic, skiing, workation and group trips to many destinations worldwide. According to audited data, in 2024, Novaturas Group recorded revenues of EUR 201 mln. and served 239 thsnd. passengers in Lithuania, Latvia and Estonia. For more information:Darius UndzėnasCFO+370 678 05749Attachments abnovaturas-2024-12-31-en Novaturas AB - Opinion 24(IFRS, SA, Conso, ESEF) EN esigned 20250609Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 hours ago
- Yahoo
Baltic Horizon Fund requests consent of investors to amend terms and conditions of outstanding bonds
Baltic Horizon Fund (the Issuer) has initiated a written procedure to amend the terms and conditions of Baltic Horizon Fund EUR 42 million 5-year floating rate bonds maturing in 2028 (ISIN EE3300003235, the Bonds). The current outstanding nominal amount of the Bonds is EUR 18,999,997.80 as Baltic Horizon Fund has redeemed Bonds in nominal amount of EUR 23,000,002.20 in accordance with the terms and conditions of the Bonds (Terms and Conditions). The Issuer has decided to request consent from the holders of the Bonds (the Holders) to amend voluntary early redemption regulation of the Bonds. The aim of the change is to give more flexibility to the Issuer to carry out voluntary early redemptions. Northern Horizon Capital AS as the fund manager has been in contact with the Holders and received preliminary consent for the requested amendments which is now to be confirmed in the official Holders' written consent procedure in accordance with the Terms and Conditions. Holders who were entered in the registry of bond-holders maintained by Nasdaq CSD SE on 6 June 2025, are entitled to vote in the written procedure. All Holders are sent a notice by Triniti Collateral Agent IX OÜ acting as the agent for Holders (the Agent). The consents of the Holders are requested to amend the regulation of voluntary early redemption regulation deriving mainly from Section 13.1 of the Terms and Conditions. Voting can be carried out by sending the filled-in voting form to the Agent by mail, courier or e-mail no later than 23:59 (EET) of 12 June 2025. The notice sent by the Agent along with the voting instructions, the voting form and template Power of Attorney are attached. For the quorum to be reached and the resolution taken the Holders representing at least 55% of the nominal amount of the Bonds should vote and Holders representing at least 2/3 of the nominal amount of the Bonds participating in the voting need to be in favour of the decision. Once a requisite majority of consents have been received by the Agent, the relevant decision shall be deemed to be adopted, even if the time period for replies has not yet expired. Information about the decision taken will be sent by notice to the Holders, published on the website of Baltic Horizon Fund and published by way of stock exchange release. If the request is approved by the Holders it will be binding on all Holders whether they participated in the voting or voted against the request or not, in accordance with Clause 16.12 of the Terms and Conditions. For additional information, please contact: Tarmo Karotam Baltic Horizon Fund manager E-mail The Fund is a registered contractual public closed-end real estate fund that is managed by Alternative Investment Fund Manager license holder Northern Horizon Capital AS. Distribution: GlobeNewswire, Nasdaq Tallinn, Nasdaq Stockholm, To receive Nasdaq announcements and news from Baltic Horizon Fund about its projects, plans and more, register on You can also follow Baltic Horizon Fund on and on LinkedIn, Facebook, X and YouTube. Attachment in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Yahoo
Tesla Delivery Estimates Cut at Oppenheimer Amid Key Market Weakness, Expected Removal of EV Credits
Tesla's (TSLA) deliveries in 2025 and 2026 will likely take a hit amid weakness in China and the Eur
